SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
67 hedge funds and large institutions have $34.2M invested in Syros Pharmaceuticals, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 25 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
80% less call options, than puts
Call options by funds: $2K | Put options by funds: $10K
Holders
67
Holding in Top 10
–
Calls
$2K
Puts
$10K
Top Buyers
| 1 | +$604K | |
| 2 | +$481K | |
| 3 | +$481K | |
| 4 |
Millennium Management
New York
|
+$435K |
| 5 |
E
Ergoteles
New York
|
+$259K |
Top Sellers
| 1 | -$2.79M | |
| 2 | -$2.55M | |
| 3 | -$1.07M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$893K |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$695K |